Literature DB >> 17657110

Familial mediterranean Fever and renal disease.

Hatem I El-Shanti1.   

Abstract

Familial Mediterranean Fever (FMF) is a genetic disorder frequently diagnosed among the Arabs. It is also prevalent among Jews, Armenians and Turks. The clinical picture consists of febrile and painful attacks such as joint or chest pain that differ in quality across patients and even within the same patient. The gene responsible for FMF, MEFV, has been cloned and mutations were identified within its coding sequence. It encodes a protein that is expected to be a down regulator of inflammation. The major renal involvement in FMF is the occurrence of amyloidosis that primarily affects the kidneys causing proteinuria and ending in death from renal failure. It can be treated by dialysis and renal transplantation, but can be prevented by a daily regimen of colchicine. Other renal manifestations of FMF are discussed.

Entities:  

Year:  2003        PMID: 17657110

Source DB:  PubMed          Journal:  Saudi J Kidney Dis Transpl        ISSN: 1319-2442


  4 in total

1.  Mesangial proliferative glomerulonephritis in familial Mediterranean fever patient with E148Q mutation: the first case report.

Authors:  Eray Eroglu; Ismail Kocyigit; Ozturk Ates; Aydin Unal; Murat Hayri Sipahioglu; Hulya Akgun; Bulent Tokgoz; Oktay Oymak
Journal:  Int Urol Nephrol       Date:  2012-01-20       Impact factor: 2.370

2.  Successful treatment with anti-tumor necrosis factor (anti-TNF)-alpha of proteinuria in a patient with familial mediterranean fever (FMF) resistant to colchicine: anti-TNF drugs and FMF.

Authors:  S Erten; S F Erten; A Altunoglu
Journal:  Rheumatol Int       Date:  2011-03-23       Impact factor: 2.631

3.  The frequency of familial mediterranean Fever related amyloidosis in renal waiting list for transplantation.

Authors:  Mustafa Keles; Nilnur Eyerci; Abdullah Uyanik; Bulent Aydinli; Gonul Zisan Sahin; Ramazan Cetinkaya; Ibrahim Pirim; Kamil Yalcin Polat
Journal:  Eurasian J Med       Date:  2010-04

4.  Fever of unknown origin in a haemodialysis patient: a late diagnosis requiring a novel treatment.

Authors:  Panagiotis Pateinakis; Chrysa Katsaounou; Dafni Meimaridou; Eleni Manou; Dorothea Papadopoulou; Dimitrios J Tsakiris
Journal:  Clin Kidney J       Date:  2014-05-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.